Pages that link to "Item:Q7805"
Jump to navigation
Jump to search
The following pages link to Scientific publication (Q7805):
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)- Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies (DOI: 10.3390/pathogens9020148) (Q7859) (← links)
- Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development (DOI: 10.3390/pathogens9020148) (Q7889) (← links)
- Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review (DOI: 10.3390/pathogens9020148) (Q7917) (← links)
- Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies (DOI: 10.3390/v12030254) (Q7918) (← links)
- Developing vaccines against epidemic-prone emerging infectious diseases (DOI: 10.1007/s00103-019-03061-2) (Q7919) (← links)
- The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application (DOI: 10.7326/m20-0504) (Q7920) (← links)
- Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals (DOI: 10.1080/09273948.2020.1738501) (Q8053) (← links)
- The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China (DOI: 10.1186/s13613-020-00653-z) (Q8284) (← links)
- Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0) (DOI: 10.1080/22221751.2020.1735265) (Q8388) (← links)
- Targeting cancer stem cell pathways for cancer therapy (DOI: 10.1038/s41392-020-0110-5) (Q8449) (← links)
- Current Trends in Diagnostics of Viral Infections of Unknown Etiology (DOI: 10.3390/v12020211) (Q10036) (← links)
- Putative contributions of circadian clock and sleep in the context of SARS-CoV-2 infection (DOI: 10.1183/13993003.01023-2020) (Q10300) (← links)
- COVID-19 and emerging viral infections: The case for interferon lambda (DOI: 10.1084/jem.20200653) (Q10304) (← links)
- Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty (DOI: 10.1007/s11886-020-01293-2) (Q10321) (← links)
- COVID-19: ICU delirium management during SARS-CoV-2 pandemic (DOI: 10.1186/s13054-020-02882-x) (Q10329) (← links)
- SARS-CoV-2: Is it the newest spark in the TORCH? (DOI: 10.1016/j.jcv.2020.104372) (Q10336) (← links)
- Trends and Prediction in Daily New Cases and Deaths of COVID-19 in the United States: An Internet Search-Interest Based Model (DOI: 10.14218/ERHM.2020.00023) (Q10341) (← links)
- Risk for Transportation of Coronavirus Disease from Wuhan to Other Cities in China (DOI: 10.3201/eid2605.200146) (Q10367) (← links)
- Site-specific glycan analysis of the SARS-CoV-2 spike (DOI: 10.1126/science.abb9983) (Q10375) (← links)
- Need for Caution in the Diagnosis of Radiation Pneumonitis in the COVID-19 Pandemic (DOI: 10.1016/j.adro.2020.04.015) (Q10381) (← links)
- Section 1: Introduction (from DOI: 10.1084/jem.20200653) (Q11178) (← links)
- Section 2: IFNs as natural broad-spectrum antivirals (from DOI: 10.1084/jem.20200653) (Q11179) (← links)
- Section 3: IFN-lambda as an antiviral drug (from DOI: 10.1084/jem.20200653) (Q11180) (← links)
- Section 4: COVID-19 treatment by IFN-lambda: Pros and cons (from DOI: 10.1084/jem.20200653) (Q11181) (← links)
- References (from DOI: 10.1084/jem.20200653) (Q11182) (← links)
- COVID-19 pathophysiology: A review (DOI: 10.1016/j.clim.2020.108427) (Q11183) (← links)
- Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response (DOI: 10.1007/s11886-020-01292-3) (Q11196) (← links)
- Protection by Exclusion (DOI: 10.1097/AOG.0000000000003924) (Q11316) (← links)
